Cross-clamp time is an independent predictor of mortality and morbidity in low- and high-risk cardiac patients  by Al-Sarraf, Nael et al.
lable at ScienceDirect
International Journal of Surgery 9 (2011) 104e109Contents lists avaiInternational Journal of Surgery
journal homepage: www.thei js .comCross-clamp time is an independent predictor of mortality and morbidity
in low- and high-risk cardiac patients
Nael Al-Sarraf a,b,*, Lukman Thalib c, Anne Hughes a, Maighread Houlihan a, Michael Tolan a,
Vincent Young a, Eillish McGovern a
aDepartment of Cardiothoracic Surgery, St. James’s Hospital, Dublin 8, Ireland
bDepartment of Cardiothoracic Surgery, Chest Disease Hospital, Kuwait city, Kuwait
cDepartment of Community Medicine (Biostatistics), Faculty of Medicine, Kuwait University, Kuwaita r t i c l e i n f o
Article history:
Received 19 May 2010
Received in revised form
18 September 2010
Accepted 13 October 2010
Available online 20 October 2010
Keywords:
Aortic cross-clamp
Mortality
Morbidity* Corresponding author. Department of Cardiotho
Hospital, P.O. Box 718, Kuwait city 46308, Kuwait. Tel
4741504.
E-mail address: trinityq8@hotmail.com (N. Al-Sarr
1743-9191/$ e see front matter  2010 Surgical Asso
doi:10.1016/j.ijsu.2010.10.007a b s t r a c t
Objectives:We sought to assess the effects of aortic cross-clamp time (XCL) on outcome following cardiac
surgery in low- and high-risk patients.
Methods: This is a retrospective review of prospectively collected departmental data of all patients who
underwent cardiac surgery over 8-year period. Our cohort consisted of 3799 consecutive patients sub-
divided into low-risk (Euro SCORE < 6, n ¼ 2691, 71%) and high-risk (Euro SCORE  6, n ¼ 1108, 29%).
Each class was further stratiﬁed into three groups based on their corresponding XCL time. Group 1
(XCL  60 min), group 2 (XCL > 60 but  90 min) and group 3 (XCL >90 min). Postoperative morbidity
and in-hospital mortality were analysed.
Results: Univariate analysis showed the following to be signiﬁcantly associated with increased XCL time
in both low- and high-risk patients: low cardiac output, prolonged ventilation time, renal complications,
prolonged hospital stay, blood transfusion and increased mortality (p < 0.05). By using multiple logistic
regression, aortic XCL time >60 min was independent risk factor for low cardiac output, prolonged
ventilation, renal complication, blood transfusion, mortality and prolonged hospital stay in both groups.
By using XCL time as a continuous variable, an incremental increase of 1 min interval in XCL time was
associated with a 2% increase in mortality in both groups.
Conclusion: Prolonged cross-clamp time signiﬁcantly correlates with major post-operative morbidity and
mortality in both low- and high-risk patients. This effect increases with increasing XCL time. Prior
knowledge on this effect can help in preventing some of these complications.
 2010 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
Historically, aortic cross-clamp (XCL) time was linked to adverse
outcome following cardiac surgery.1e3 However, whether or not
XCL time has the same effect on low- vs. high-risk cardiac surgery
patients remains unknown. In this study we have attempted to link
the effect of XCL time to post-operative outcome in both low- and
high-risk patients, thereby increasing our understanding of its
potential implication in the cardiac surgery setting with the hope of
potentially reducing its deleterious effect.racic Surgery, Chest Disease
.: þ965 66600543; fax: þ965
af).
ciates Ltd. Published by Elsevier Lt2. Patients and methods
2.1. Patients
This is a retrospective review of a prospectively collected depart-
mental database (Patient Analysis and Tracking System, Dendrite
Clinical, UK). All patients who underwent coronary artery bypass
graft (CABG), isolated valve surgery (mitral, aortic, tricuspid or
combination), or both in department of cardiothoracic surgery at St.
James hospital between the period of February 2000 and July 2008
were reviewed. A total of 3799 consecutive patientswere included in
the study. All data were collected prospectively in a departmental
database through the input of a dedicated database manager. Euro
SCORE4 was used to stratify patients into low-risk (i.e. Euro
SCORE< 6) and high-risk (i.e. Euro SCORE 6) groups. Each of these
two groups was analysed separately. Each of these two subsets was
then stratiﬁed into 3 subgroups based on their aortic cross-clampd. All rights reserved.
Table 1
Preoperative characteristics and their distribution among the various groups with
Euro SCORE < 6 (n ¼ 2691).
Variable Time  60 min
(control)
(n ¼ 1510)
Time > 60
to 90 min
(n ¼ 859)
Time > 90
min
(n ¼ 322)
P-value
Age (years)
Mean  SD 63.6  9.5 64.5  10.4 65.2  11.6 0.015
Gender
Female 344 (23%) 220 (26%) 91 (28%)
Male 1166 (77%) 639 (74%) 231 (72%) 0.066
Angina (CCS) class
0e2 623 (41%) 455 (53%) 213 (66%)
3e4 887 (59%) 404 (47%) 109 (34%) <0.001
NYHA score
II 923 (61%) 465 (54%) 115 (36%)
>II 587 (39%) 394 (46%) 207 (64%) <0.001
Heart failure
Yes 180 (12%) 186 (22%) 149 (46%)
No 1330 (88%) 673 (78%) 173 (54%) <0.001
Number of MI
None 848 (56%) 548 (64%) 236 (73%)
One 547 (36%) 254 (29%) 65 (20%)
Two or more 115 (8%) 57 (7%) 21 (7%) <0.001
Interval of MI to surgery
None 848 (56%) 548 (64%) 236 (73%)
<90 days 305 (20%) 150 (17%) 38 (12%)
>90 days 357 (24%) 161 (19%) 48 (15%) <0.001
Diabetes mellitus
None 1223 (81%) 705 (82%) 270 (84%)
Insulin dependent 60 (4%) 39 (5%) 6 (2%)
Non-insulin dependent 227 (15%) 115 (13%) 46 (14%) 0.225
Hypercholesterolemia
Yes 1117 (74%) 525 (61%) 164 (51%)
No 393 (26%) 334 (39%) 158 (49%) <0.001
Hypertension
Yes 827 (55%) 450 (52%) 151 (47%)
No 683 (45%) 409 (48%) 171 (53%) 0.033
Smoking status
Current smokers 247 (16%) 120 (14%) 47 (15%)
Former smokers 827 (55%) 437 (51%) 158 (49%)
Non-smokers 436 (29%) 302 (35%) 117 (36%) 0.008
Chronic obstructive pulmonary disease
Yes 135 (9%) 86 (10%) 40 (12%)
No 1375 (91%) 773 (90%) 282 (88%) 0.148
Cerebrovascular accident
Yes 108 (7%) 86 (10%) 34 (11%)
No 1402 (93%) 773 (90%) 288 (89%) 0.020
Peripheral vascular disease
Yes 277 (18%) 113 (13%) 40 (12%)
No 1233 (82%) 746 (87%) 282 (88%) 0.001
Arrhythmia
Yes 115 (8%) 128 (15%) 104 (32%)
No 1395 (92%) 731 (85%) 218 (68%) <0.001
Extra-cardiac arteriopathy
Yes 97 (6%) 53 (6%) 18 (6%)
No 1413 (94%) 806 (94%) 304 (94%) 0.849
Extent of coronary artery disease
Normal 99 (6%) 245 (29%) 110 (34%)
Single/double 372 (25%) 103 (12%) 97 (30%)
Triple 1039 (69%) 511 (59%) 115 (36%) <0.001
Left main stem disease
Yes 420 (28%) 171 (20%) 41 (13%) <0.001
No 1090 (72%) 688 (80%) 281 (87%)
Ejection fraction
<50% 543 (36%) 355 (41%) 153 (48%)
50% 967 (64%) 504 (59%) 169 (52%) <0.001
Intra-aortic balloon pump
Yes 23 (2%) 7 (1%) 4 (1%)
No 1487 (98%) 852 (99%) 318 (99%) 0.332
Priority
Elective/urgent 1441 (95%) 837 (97%) 303 (94%)
Emergency/salvage 69 (5%) 22 (3%) 19 (6%) 0.013
Cardiac procedure
Isolated CABG 1393 (92%) 508 (59%) 41 (13%)
CABG þ valve 9 (1%) 91 (11%) 163 (50%)
Isolated valve 108 (7%) 260 (30%) 118 (37%) <0.001
Table 1 (continued)
Variable Time  60 min
(control)
(n ¼ 1510)
Time > 60
to 90 min
(n ¼ 859)
Time > 90
min
(n ¼ 322)
P-value
Body mass index (kg/m2)
Mean  SD 27.6  4.6 27.6  4.6 26.7  4.3 0.006
Cardiopulmonary bypass time (minutes)
Mean  SD 84.7  22.4 116.0  23.4 156.4  42.3 <0.001
CABG: Coronary artery bypass graft; CCS: Canadian cardiovascular society; NYHA:
New York heart association; MI: Myocardial infarction; SD: Standard deviation.
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2 is clamp time >60 mine90 min and group 3 is clamp time
>90min. Outcomemeasures studied included in-hospitalmortality,
post-operative complications, length of hospital stay and intensive
care unit (ICU) stay. This study and the departmental database were
both approved by our institutional review board. Individual patient
consent was obtained for entry into the database. However, our
institutional review board waived the need for individual patient
consent for this study.2.2. Cardiopulmonary bypass (CPB) and deﬁnitions
All cardiac surgeries were performed through a median ster-
notomy with CPB. Our CPB technique and myocardial protection
have been previously reported.5 Following full anticoagulationwith
heparin given at a dose of 300 IU/kg to maintain an activated
clotting time of 400e600 s, CPB was instituted using ascending
aortic cannulation and a two-stage right atrial venous cannulation.
A roller pump (jostra HL 20) and hollow-ﬁbre membrane oxygen-
ator (Optima, Cobe Cardiovascular Inc.) were used. The extracor-
poreal circuit was primed with 1400 ml of Hartmann’s solution and
5000 IU heparin. CPB was maintained with non-pulsatile ﬂowwith
a minimum ﬂow rate of 2.4 L/m2/min at normothermia with
temperature was allowed to drift to 32 C. Arterial line ﬁltration
(Sentoy, Cobe Cardiovascular Inc.) was used in all the cases. Shed
blood was recycled using cardiotomy suction. Acid-base was
managed with alpha stat control. Myocardial protection was ach-
ieved with intermittent antegrade cold/tepid blood cardioplegia.
On completion of all distal anastomoses, the aortic cross-clampwas
removed and the proximal anastomoses performed with partial
aortic clamping. Valvular surgeries were performed under single
aortic cross-clamp. In CABG and valve surgeries, the cardioplegia is
given in an antegrade fashion through the distal anastomotic grafts
which were constructed ﬁrst. Heparin was reversed with prot-
amine at 1:1 ratio on weaning off cardiopulmonary bypass.5
Operative priority was determined by cardiothoracic surgeons
according to standard criteria as we have previously reported.6
Deﬁnitions for in-hospital mortality and complications (i.e. renal,
neurological, gastrointestinal, pulmonary, infective and arrhyth-
mias) were previously reported in detail.7,8 Additive Euro SCORE
was used in the risk stratiﬁcation of cardiac surgery patients.42.3. Data analysis
We used logistic regression models to assess the relationship
between the early binary clinical outcomes including in-hospital
mortality and post-operative complications with the aortic cross-
clamp time. Crude odds ratios, 95% conﬁdence intervals along with
the related P-values were obtained using univariate logistic
regression. Adjusted odds ratios (OR) were obtained using multi-
variate logistic models accounting for possible confounding. High-
risk and low-risk patients were analysed separately. In addition,
multiple logistic regression was used to examine the effect of
Table 3
Crude odds ratios for early clinical outcomes of aortic cross-clamp time in patients
with Euro SCORE < 6 using multiple logistic regression (n ¼ 2691).
Variable a Time  60 min
OR (95% CI)
Time > 60
 90 min
Time
> 90 min
N. Al-Sarraf et al. / International Journal of Surgery 9 (2011) 104e109106incremental increase in aortic cross-clamp time on mortality as
a continuous variable using 1 min increments of XCL time. All data
were entered and analysed using SPSS version 17 (SPSS Inc., USA).
The P-values were considered statistically signiﬁcant when less
than 0.05.OR (95% CI) OR (95% CI)
Post-op low cardiac output
(Inotropes  IABP)
1.0 (e) 1.4 (1.2e1.7)* 3.2 (2.5e4.1)*
Re-operation 1.0 (e) 1.6 (1.1e2.3)* 2.8 (1.8e4.2)*
Ventilation time
(<24 vs. >24 h)
1.0 (e) 1.5 (1.1e2.1)* 4.2 (3.0e6.0)*
Post-op arrhythmias 1.0 (e) 1.1 (0.9e1.3) 1.1 (0.9e1.5)
Pulmonary complications 1.0 (e) 1.2 (1.0e1.6)* 2.0 (1.5e2.7)*
Infective complications 1.0 (e) 1.2 (0.9e1.6) 2.0 (1.4e3.0)*
Renal complications 1.0 (e) 1.4 (1.0e1.9)* 2.1 (1.5e3.1)*
Gastrointestinal
complications
1.0 (e) 1.4 (0.8e2.7) 4.4 (2.4e8.4)*
Neurological complications 1.0 (e) 1.9 (1.1e3.2) 0.7 (0.2e1.9)
Readmission to ICU 1.0 (e) 1.6 (1.0e2.5)* 2.3 (1.3e3.9)*
ICU stay (days) 1.0 (e) 1.3 (1.1e1.6)* 3.0 (2.4e3.9)*
Post-op stay (days) 1.0 (e) 1.7 (1.5e2.1)* 3.5 (2.7e4.6)*
Blood transfusion 1.0 (e) 1.5 (1.3e1.8)* 3.3 (2.5e4.2)*
In-hospital mortality 1.0 (e) 1.7 (1.0e2.7)* 3.4 (2.0e5.8)*
CI: conﬁdence interval; IABP: intra-aortic balloon pump; ICU: intensive care unit;
OR: odds ratio.
a signiﬁcant variables are highlighted with asterisk.3. Results
Our cohort (n ¼ 3799) consisted of 936 (25%) females and 2863
(75%) males. Age ranged from 19 to 89 years old with a mean (1
SD) of 63.9 (10.1) years old. In-hospital mortality overall was 3.5%
(133 patients). The cohort was subdivided into two subsets based
on the Euro SCORE stratiﬁcation of surgical risk. The ﬁrst subset
included low-risk patients with Euro SCORE< 6 (n¼ 2691, 71%) and
the second subset included high-risk patients with Euro SCORE  6
(n ¼ 1108, 29%). Both of these groups were then divided into three
groups based on their XCL time as follows: clamp time 60 min
(control group), clamp time >60 but  90 min, and clamp time
>90 min. Results hereby are presented in a systemic order:
Tables 1e4 are for patients with Euro SCORE < 6, and Tables 5e8
are results for patients with Euro SCORE  6. Preoperative factors
and patients characteristics are summarized in Table 1 for patients
with Euro SCORE < 6 and their corresponding post-operativeTable 2
Univariate analysis of post-operative complications in the various groups with Euro
SCORE < 6 (n ¼ 2691).
Variable Time  60 min
(control)
(n ¼ 1510)
Time > 60
to 90 min
(n ¼ 859)
Time > 90 min
(n ¼ 322)
P-value
Low cardiac output
Inotropes  IABP 556 (37%) 389 (45%) 210 (65%)
None 954 (63%) 470 (55%) 112 (35%) <0.001
Arrhythmias
Yes 747 (49%) 441 (51%) 170 (53%)
No 763 (51%) 418 (49%) 152 (47%) N/S
Re-operation
Yes 68 (5%) 60 (7%) 37 (11%)
No 1442 (95%) 799 (93%) 285 (89%) <0.001
Ventilation time
<24 h 1426 (94%) 790 (92%) 258 (80%)
>24 h 84 (6%) 69 (8%) 64 (20%) <0.001
Pulmonary complications
Yes 220 (15%) 153 (18%) 82 (25%)
No 1290 (85%) 706 (82%) 240 (75%) <0.001
Neurological complications
Yes 28 (2%) 30 (3%) 4 (1%)
No 1482 (98%) 829 (97%) 318 (99%) 0.015
Infective complications
Yes 106 (7%) 71 (8%) 43 (13%)
No 1404 (93%) 788 (92%) 279 (87%) 0.001
Renal complications
Yes 102 (7%) 80 (9%) 43 (13%)
No 1408 (93%) 779 (91%) 279 (87%) <0.001
Gastrointestinal complications
Yes 21 (1%) 17 (2%) 19 (6%)
No 1489 (99%) 842 (98%) 303 (94%) <0.001
Readmission to ICU
Yes 43 (3%) 39 (5%) 20 (6%)
No 1467 (97%) 820 (95%) 302 (94%) 0.006
ICU stay (days)
Mean  SD 2.0  4.0 3.2  9.3 4.3  8.3 <0.001
Post-op stay (days)
Mean  SD 8.2  9.7 10.3  14.8 12.9  14.2 <0.001
Blood transfusion
Yes 597 (40%) 424 (49%) 219 (68%)
No 913 (60%) 435 (51%) 103 (32%) <0.001
Status
Alive 1474 (98%) 825 (96%) 297 (92%)
Dead 36 (2%) 34 (4%) 25 (8%) <0.001
IABP: Intra-aortic balloon pump; ICU: Intensive care unit; SD: standard deviation.complications is summarized in Table 2, with their relevant
p-values as determined by univariate analysis. Crude odd ratios and
adjusted odd ratios (OR) for early clinical outcomes of aortic cross-
clamp time in patients with Euro SCORE < 6 using univariate and
multiple logistic regression are summarized in Tables 3 and 4
respectively. The rate of most post-operative complications
showed a signiﬁcantly steady increase as the aortic XCL time
increased with the exception of neurological complications and
arrhythmias (Table 2). Similarly, the length of both hospital stay and
intensive care unit (ICU) stay also showed a signiﬁcantly steady
increase with the incremental increase in aortic XCL time (Table 2).
In addition, in-hospital mortality and blood transfusion require-
ments both showed similar association with aortic XCL time. By
using multiple logistic regression, post-operative complicationsTable 4
Adjusted odds ratios (by age and gender) related to early clinical outcomes of aortic
cross-clamp time in patients with Euro SCORE < 6 using multiple logistic regression
(n ¼ 2691).
Variable a Time  60 min
OR (95% CI)
Time
> 60  90 min
OR (95% CI)
Time
> 90 min
OR (95% CI)
Post-op low cardiac output
(Inotropes  IABP)
1.0 (e) 1.4 (1.2e1.6)* 3.2 (2.4e4.1)*
Re-operation 1.0 (e) 1.6 (1.1e2.2)* 2.6 (1.7e4.0)*
Ventilation time
(<24vs. >24 h)
1.0 (e) 1.4 (1.0e2.0)* 3.9 (2.7e5.6)*
Post-op arrhythmias 1.0 (e) 1.0 (0.9e1.2) 1.1 (0.8e1.4)
Pulmonary complications 1.0 (e) 1.2 (1.0e1.6) 1.9 (1.4e2.6)*
Infective complications 1.0 (e) 1.2 (0.9e1.6) 2.0 (1.4e2.9)*
Renal complications 1.0 (e) 1.3 (1.0e1.8) 1.9 (1.3e2.7)*
Gastrointestinal
complications
1.0 (e) 1.4 (0.7e2.6) 4.0 (2.1e7.6)*
Neurological
complications
1.0 (e) 1.8 (1.1e3.1) 0.6 (0.2e1.7)
Readmission to ICU 1.0 (e) 1.6 (1.0e2.5)* 2.2 (1.2e3.7)*
ICU stay (days) 1.0 (e) 1.3 (1.1e1.6)* 2.9 (2.3e3.7)*
Post-op stay (days) 1.0 (e) 1.7 (1.4e2.0)* 3.5 (2.7e4.6)*
Blood transfusion 1.0 (e) 1.4 (1.2e1.7)* 3.3 (2.5e4.3)*
In-hospital mortality 1.0 (e) 1.6 (1.0e2.6)* 3.1 (1.8e5.3)*
CI: conﬁdence interval; IABP: intra-aortic balloon pump; ICU: intensive care unit;
OR: odds ratio.
a Signiﬁcant variables are highlighted with asterisk.
Table 5
Preoperative characteristics and their distribution among the various groups with
Euro SCORE  6 (n ¼ 1108).
Variable Time
 60 min
(control)
(n ¼ 618)
Time > 60
to 90 min
(n ¼ 362)
Time
> 90 min
(n ¼ 128)
P-value
Age (years)
Mean  SD 63.4  9.3 63.8  11.3 64.9  11.7 0.311
Gender
Female 165 (27%) 80 (22%) 36 (28%)
Male 453 (73%) 282 (78%) 92 (72%) 0.209
Angina (CCS) class
0e2 272 (44%) 190 (52%) 85 (66%)
3e4 346 (56%) 172 (48%) 43 (34%) <0.001
NYHA score
II 385 (62%) 202 (56%) 47 (37%)
>II 233 (38%) 160 (44%) 81 (63%) <0.001
Heart failure
Yes 68 (11%) 65 (18%) 55 (43%)
No 550 (89%) 297 (82%) 73 (57%) <0.001
Number of MI
None 344 (56%) 242 (67%) 100 (78%)
One 237 (38%) 90 (25%) 25 (20%)
Two or more 37 (6%) 30 (8%) 3 (2%) <0.001
Interval of MI to surgery
None 344 (56%) 242 (67%) 100 (78%)
<90 days 126 (20%) 44 (12%) 13 (10%)
>90 days 148 (24%) 76 (21%) 15 (12%) <0.001
Diabetes mellitus
None 503 (81%) 309 (85%) 107 (84%)
Insulin dependent 25 (4%) 11 (3%) 4 (3%)
Non-insulin dependent 90 (15%) 42 (12%) 17 (13%) 0.615
Hypercholesterolemia
Yes 477 (77%) 216 (60%) 65 (51%)
No 141 (23%) 146 (40%) 63 (49%) <0.001
Hypertension
Yes 364 (59%) 207 (57%) 58 (45%)
No 254 (41%) 155 (43%) 70 (55%) 0.018
Smoking status
Current smokers 88 (14%) 54 (15%) 16 (12%)
Former smokers 340 (55%) 199 (55%) 65 (51%)
Non-smokers 190 (31%) 109 (30%) 47 (37%) 0.702
Chronic obstructive pulmonary disease
Yes 48 (8%) 34 (9%) 21 (16%)
No 570 (92%) 328 (91%) 107 (84%) 0.009
Cerebrovascular accident
Yes 47 (8%) 25 (7%) 10 (8%)
No 571 (92%) 337 (93%) 118 (92%) 0.905
Peripheral vascular disease
Yes 107 (17%) 45 (12%) 24 (19%)
No 511 (83%) 317 (88%) 104 (81%) 0.084
Arrhythmia
Yes 46 (7%) 56 (15%) 41 (32%)
No 572 (93%) 306 (85%) 87 (68%) <0.001
Extra-cardiac arteriopathy
Yes 35 (6%) 27 (7%) 8 (6%)
No 583 (94%) 335 (93%) 120 (94%) 0.537
Extent of coronary artery disease
Normal 36 (6%) 92 (26%) 44 (34%)
Single/double 172 (28%) 48 (13%) 39 (31%)
Triple 410 (66%) 222 (61%) 45 (35%) <0.001
Left main stem disease
Yes 189 (31%) 72 (20%) 14 (11%)
No 429 (69%) 290 (80%) 114 (89%) <0.001
Ejection fraction
<50% 207 (33%) 134 (37%) 54 (42%)
50% 411 (67%) 228 (63%) 74 (58%) 0.140
Intra-aortic balloon pump
Yes 4 (1%) 5 (1%) 2 (2%)
No 614 (99%) 357 (99%) 126 (98%) 0.421
Priority
Elective/urgent 602 (97%) 350 (97%) 123 (96%)
Emergency/salvage 16 (3%) 12 (3%) 5 (4%) 0.655
Cardiac procedure
Isolated CABG 570 (92%) 217 (60%) 19 (15%)
CABG þ valve 3 (1%) 47 (13%) 62 (48%)
(continued on next page)
Table 5 (continued )
Variable Time
 60 min
(control)
(n ¼ 618)
Time > 60
to 90 min
(n ¼ 362)
Time
> 90 min
(n ¼ 128)
P-value
Isolated valve 45 (7%) 98 (27%) 47 (37%) <0.001
Body mass index (kg/m2)
Mean  SD 28.1  5.8 27.6  4.6 27.6  4.7 0.298
Cardiopulmonary bypass time (min)
Mean  SD 84.3  22.6 116.9  23.8 157.1  42.9 <0.001
CABG: Coronary artery bypass graft; CCS: Canadian cardiovascular society;
MI: Myocardial infarction; NYHA: New York heart association; SD: Standard
deviation.
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were: low cardiac output, re-operation, prolonged ventilation,
pulmonary, infective, renal and gastrointestinal complications.
Similarly, the rate of ICU readmission together with both hospital
and ICU staywere signiﬁcantly associatedwith prolonged XCL time.
In-hospital mortality rate was highest in patients with XCL time
>90 min (OR 3.1) and intermediate in XCL time >60 min  90 min
(OR 1.6) relative to the control group (XCL time <60 min). Blood
transfusion requirement (Table 4) were also signiﬁcantly increased
in patients with prolonged XCL time (OR 3.3 for XCL > 90 min, and
OR 1.4 for XCL > 60  90 min).Table 6
Univariate analysis of post-operative complications in the various groups with Euro
SCORE  6 (n ¼ 1108).
Variable Time  60 min
(control)
(n ¼ 618)
Time > 60
to 90 min
(n ¼ 362)
Time
> 90 min
(n ¼ 128)
P-value
Post-op low cardiac output
Inotropes  IABP 217 (35%) 137 (38%) 80 (63%)
None 401 (65%) 225 (62%) 48 (37%) <0.001
Arrhythmias
Yes 308 (50%) 179 (49%) 58 (45%)
No 310 (50%) 183 (51%) 70 (55%) 0.643
Re-operation
Yes 35 (6%) 22 (6%) 5 (4%)
No 583 (94%) 340 (94%) 123 (96%) 0.652
Ventilation time
<24 h 591 (96%) 339 (94%) 109 (85%)
>24 h 27 (4%) 23 (6%) 19 (15%) <0.001
Pulmonary complications
Yes 93 (15%) 61 (17%) 28 (22%)
No 525 (85%) 301 (83%) 100 (78%) 0.160
Neurological complications
Yes 15 (2%) 8 (2%) 6 (5%)
No 603 (98%) 354 (98%) 122 (95%) 0.290
Infective complications
Yes 47 (8%) 38 (10%) 16 (12%)
No 571 (92%) 324 (90%) 112 (88%) 0.116
Renal complications
Yes 35 (6%) 33 (9%) 16 (12%)
No 583 (94%) 329 (91%) 112 (88%) 0.012
Gastrointestinal complications
Yes 9 (1%) 10 (3%) 4 (3%)
No 609 (99%) 352 (97%) 124 (97%) 0.259
Readmission to ICU
Yes 22 (4%) 10 (3%) 5 (4%)
No 596 (96%) 352 (97%) 123 (96%) 0.743
ICU stay (days)
Mean  SD 1.9  3.6 2.5  5.8 3.5  9.8 0.008
Post-op stay (days)
Mean  SD 7.8  6.7 8.7  9.5 13.6  20.3 <0.001
Blood transfusion
Yes 271 (44%) 169 (47%) 89 (70%)
No 347 (56%) 193 (53%) 39 (30%) <0.001
Status
Alive 608 (98%) 344 (95%) 118 (92%)
Dead 10 (2%) 18 (5%) 10 (8%) <0.001
IABP: Intra-aortic balloon pump; ICU: Intensive care unit; SD: standard deviation.
Table 7
Crude odds ratios for early clinical outcomes of aortic cross-clamp time in patients
with Euro SCORE  6 using multiple logistic regression (n ¼ 1108).
Variable Time
 60 min
OR (95% CI)
Time > 60
 90 min
OR (95% CI)
Time > 90 min
OR (95% CI)
Post-op low cardiac output
(Inotropes  IABP)
1.0 (e) 1.1 (0.9e1.5) 3.1 (2.1e4.6)*
Post-op arrhythmias 1.0 (e) 1.0 (0.8e1.3) 0.8 (0.6e1.2)
Re-operation 1.0 (e) 1.1 (0.6e1.9) 0.7 (0.3e1.8)
Ventilation time
(<24 vs. >24 h)
1.0 (e) 1.5 (0.8e2.6) 3.8 (2.1e7.1)*
Pulmonary complications 1.0 (e) 1.1 (0.8e1.6) 1.6 (1.0e2.5)
Neurological complications 1.0 (e) 0.9 (0.4e2.2) 2.0 (0.8e5.2)
Infective complications 1.0 (e) 1.4 (0.9e2.2) 1.7 (1.0e3.2)
Renal complications 1.0 (e) 1.7 (1.0e2.7)* 2.4 (1.3e4.4)*
Gastrointestinal complications 1.0 (e) 1.9 (0.8e4.8) 2.2 (0.7e7.2)
Re-admission to ICU 1.0 (e) 0.8 (0.4e1.6) 1.1 (0.4e3.0)
Intensive care stay (days) 1.0 (e) 1.2 (0.9e1.5) 2.3 (1.6e3.5)*
Hospital stay (days) 1.0 (e) 1.3 (1.0e1.6) 3.0 (2.0e4.6)*
Blood transfusion 1.0 (e) 1.1 (0.9e1.5) 2.9 (1.9e4.4)*
In-hospital mortality 1.0 (e) 3.2 (1.5e7.0)* 5.2 (2.1e12.7)*
Signiﬁcant variables are highlighted with asterisk.
IABP: Intra-aortic balloon pump; CI: conﬁdence interval; OR: odd ratio.
Table 9
Multiple logistic regression analysis showing the effect of aortic cross-clamp time as
a continuous variable on in-hospital mortality using 1min increments of XCL time in
both groups.
Aortic cross-clamp time In-hospital mortality
Euro SCORE < 6 Euro SCORE  6
Mortality (n/N) 95/2691 38/1108
Odds ratio 1.02 1.02
95% Conﬁdence interval 1.01e1.03 1.01e1.03
P-value <0.001 <0.001
n: number of patients with observed outcome; N: total number of sample.
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are shown in Tables 5e8. Preoperative factors and patients char-
acteristics are summarized in Table 5with their relevant p-values as
determined by univariate analysis while Table 6 is a summary of the
univariate analysis of post-operative complications in this group. As
shown in Table 6, the rate of following post-operative complica-
tions was signiﬁcantly increased with increasing aortic XCL time:
low cardiac output, prolonged ventilation time, renal complica-
tions, ICU and hospital stay. All of these have shown a steady
incremental increase in relation to the incremental increase in
aortic XCL time. Furthermore, the blood transfusion requirements
and in-hospital mortality also showed a signiﬁcant correlationwith
the increase in aortic XCL time. Crude odd ratios and adjusted odd
ratios for early clinical outcomes of aortic cross-clamp time in
patients with Euro SCORE 6 using univariate andmultiple logistic
regression are summarized in Tables 7 and 8 respectively. As shown
in these tables, low cardiac output, prolonged ventilation time,
renal complications, hospital and intensive care unit stays and
blood transfusion requirements were all signiﬁcantly increased as
the aortic XCL time is increased. Similarly, mortality for high-riskTable 8
Adjusted odds ratios (by age and gender) related to early clinical outcomes of aortic
cross-clamp time in patients with Euro SCORE  6 using multiple logistic regression
(n ¼ 1108).
Variable a Time
 60 min
OR (95% CI)
Time > 60
 90 min
OR (95% CI)
Time > 90 min
OR (95% CI)
Post-op low cardiac output
(inotropes  IABP)
1.0 (e) 1.1 (0.8e1.5) 3.0 (2.0e4.5)*
Arrhythmias 1.0 (e) 1.0 (0.7e1.2) 0.7 (0.5e1.1)
Re-operation 1.0 (e) 1.1 (0.6e1.8) 0.6 (0.2e1.7)
Ventilation time (<24 vs. >24 h) 1.0 (e) 1.5 (0.8e2.6) 3.8 (2.0e7.0)*
Pulmonary complications 1.0 (e) 1.1 (0.8e1.6) 1.5 (1.0e2.5)
Neurological complications 1.0 (e) 0.9 (0.4e2.1) 1.8 (0.7e4.8)
Infective complications 1.0 (e) 1.4 (0.9e2.2) 1.7 (0.9e3.1)
Renal complications 1.0 (e) 1.6 (1.0e2.6) 2.2 (1.2e4.2)*
Gastrointestinal complications 1.0 (e) 1.7 (0.7e4.4) 1.9 (0.6e6.3)
Intensive care stay (days) 1.0 (e) 1.3 (1.0e1.6) 3.0 (2.0e4.6)*
Readmission to ICU 1.0 (e) 0.8 (0.4e1.6) 1.0 (0.4e2.8)
Hospital stay (days) 1.0 (e) 1.2 (0.9e1.5) 2.3 (1.6e3.4)*
Blood transfusion 1.0 (e) 1.1 (0.9e1.5) 3.0 (1.9e4.5)*
In-hospital mortality 1.0 (e) 3.1 (1.4e6.8)* 4.7 (1.9e11.7)*
IABP: Intra-aortic balloon pump; CI: conﬁdence interval; OR: odds ratio.
a Signiﬁcant variables are highlighted with asterisk.patients with prolonged aortic XCL time>90minwere signiﬁcantly
higher (OR 4.7) than those with XCL time >60  90 min (OR 3.1).
A separate multiple logistic regression examining the effect of
1 min incremental increase in aortic cross-clamp time (as a contin-
uous variable) on the risk ofmortality in both groups is summarized
in Table 9. As shown in this table, for every 1 min increase in XCL
time, the odds of mortality increases by 2% (OR 1.02) [95% CI
1.01e1.03 P-value <0.001]. This was observed for both groups.4. Discussion
Previous studies have highlighted increased risk of death and
some complications in patients who are subjected to prolonged
aortic cross-clamp time.1e3 However, no data are available on the
effect of aortic XCL time in both low- and high-risk cardiac surgery
patients. In addition, the full spectrum of complications as a func-
tion of prolonged aortic cross-clamp time has not been reported in
great detail. In this paper we sought to assess the relation between
prolonged aortic XCL time and outcome in both low- and high-risk
patients. By doing so, our understanding of the clinical signiﬁcance
of such clamp time will be strengthened leading to a better
potential preventative strategies that can improve the clinical
outcome.
As speculated, we found that prolonged aortic XCL time signif-
icantly correlated with worse clinical outcomes in both low-risk
and high-risk cardiac surgery patients. The spectrum of complica-
tions included in-hospital mortality, prolonged hospitalization,
prolonged ventilation, low cardiac output, higher requirements for
blood transfusion and renal complications (Tables 4 and 8). This
effect was similar in both low- and high-risk groups. Few previous
studies have examined predictors of in-hospital mortality and
among these, prolonged aortic XCL time was found to be signiﬁ-
cant.1,2,9 However, all previous data were either presented as mean
value of XCL time2 or various differing cut-off values.1,9 Doenst et al.
have shown that prolonged XCL time was signiﬁcant predictor of
mortality in patients with ejection fraction>40%, but no correlation
was shown with those with ejection fraction <40%.1 The authors
speculated that this lack of correlation was mainly due to high
mortality seen in their series in patients with EF <40% at very short
XCL times (<30 min). Our ﬁndings ﬁt to some degree with those
reported by Doenst et al., in that prolonged XCL time are associated
with mortality in a linear fashion. However, in their work the
mortality for patients with depressed ejection fraction (<40%), they
observed a U-shaped curve with highest mortality seen in both
ends of XCL time (i.e. <30 min and >90 < 120 min). A limitation to
their work is that they did not stratify their cases on the basis of any
risk scoring system as we have done, which might have potentially
altered the results especially among the depressed ejection fraction
group. Stratifying patients on the mere basis of their preoperative
ejection fraction is not a true representative way of describing the
mortality risk. In addition, some of these studies have also excluded
patients with prolonged ischemic time1 and no study so far have
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the overall effect, as we have done.
Few potential reasons can explain the observed association
between in-hospital mortality and prolonged aortic XCL time.
Firstly, the range of post-operative complications observed in both
groups of low- and high-risk patients in our study as a result of
prolonged aortic XCL time were wide and included blood trans-
fusion requirements, low cardiac output, prolonged ventilation,
renal complications and prolonged hospital and ICU stay (Tables 4
and 8). In addition, low-risk groups with prolonged aortic XCL
time had also higher rates of infective complications, pulmonary
complications and gastrointestinal complications (Table 4). All of
these complications can arise as a result of prolonged ischemia time
and can directly affect post-operative mortality. For example, blood
transfusion has been signalled previously to be as a signiﬁcant
occurring in cardiac surgery patients with prolonged aortic XCL
time3 and was reported to be associated with worse outcome
following cardiac surgery.10 In addition, renal failure post-cardiac
surgery is also independently associated with mortality as we have
previously shown among others.5,11 Secondly, aortic XCL time is
considered to reﬂect ischemic injury and despite better myocardial
protection techniques used in the current era, it is still noted to affect
mortality.1 This is clearly shown inTable 9,where 1min incremental
increase in aortic cross-clamp time is associated with 2% increase in
mortality (OR 1.02) in both groups. Thirdly, in the past, authors have
shown that there is an increase in the catecholamine release as
measured by epinephrine and norepinephrine levels during XCL of
aorta.12 This effect could be ampliﬁed by prolonged XCL time and as
suchwewould expect amore pronounced effect of this sympathetic
activation. Unfortunately, no study so far has elicited themechanism
bywhich aortic cross-clamp canproduce its effects and such studies
are desperately needed to understand more about the pathophysi-
ological mechanisms underlying these effects.
There was no association between prolonged aortic cross-clamp
time and arrhythmias and neurological complications following
cardiac surgery. Arrhythmias are the result of hyper adrenergic
stimulation that occurs following the stress of cardiac surgery and
the use of inotropic medications post-surgery rather than ischemic
time. Previous studies examining predictors of post-operative
arrhythmias have shown lack of association between ischemic time
and arrhythmias.13,14 Neurological complications are the result of
multiple preoperative and intraoperative factors such as advanced
age, peripheral vascular disease, diabetes, aortic calciﬁcations and
intraoperative hypoperfusion rather than prolonged ischemic
time.15,16 The main hypothesis of neurological complications is
direct embolization of unstable aortic plaques following aortic
clamping rather than aortic cross-clamp time itself.5. Limitation of the study
There are few limitations in our study. Firstly, our study remains
a retrospective study despite the fact that all data were prospec-
tively collected, and as such we can only report an association
rather than causality. Secondly, some preoperative characteristics
that were signiﬁcantly different among the three groups could have
contributed to the observed outcome. However, we relied on Euro
SCORE for stratifying patients into low- and high-risk groups,
thereby potentially limiting such an association to affect the
observed outcome. Euro SCORE has one of the highest sensitivities
and speciﬁcities amongmost cardiac surgery risk scoring systems.17
However, within these acceptable limitations, we believe our work
will shed more light into the subject and perhaps stimulate more
research on this topic.6. Conclusion
Prolonged aortic cross-clamp time signiﬁcantly correlates with
major post-operative morbidity and mortality in both low- and
high-risk cardiac surgery patients. This effect increases with
increasing XCL time. Prior knowledge on this effect can help in
preventing some of these complications or reducing their inci-
dence. Studies aimed at elucidating the mechanisms of these
deleterious effects at cellular level are warranted.
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